openPR Logo
Press release

Asia Pacific Multiple Myeloma therapeutics market growing at a CAGR of 5.5%

06-22-2017 11:15 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Market Data Forecast

Market Data Forecast

Market Data Forecast

“Asia Pacific Multiple Myeloma Therapeutics market" research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 5.5% to reach USD 1.79 billion by 2021, from USD 1.37 billion in 2016.

Multiple myeloma is a cancer of the plasma cells located in the bone marrow. The exact cause of multiple myeloma is not known. Risk factors for multiple myeloma have not been properly established although researchers have suggested that genetic abnormalities, such as c-Myc genes or environmental exposures, may play a role. Symptoms of MM can include bone Pain, pathologic fractures, weakness, malaise, bleeding and anemia, infection, hypercalcemia, spinal cord compression, renal failures, and neuropathies.

Request Sample: http://www.marketdataforecast.com/market-reports/asia-pacific-multiple-myeloma-therapeutics-market-861/request-sample

The report presents a detailed analysis of multitude of factors affecting the multiple myeloma therapeutics market bearing either positive or negative outcomes. Some of those factors are

• Growing population
• Rise in ageing population
• Development of novel therapeutics
• Absence of standard competition in major Asia Pacific countries
• Evolving treatment techniques for multiple myeloma
• High cost associated with the treatment of the disease

For granular level understanding the multiple myeloma Therapeutics market is segmented based on treatment type and drug type. By treatment type the market is further segmented into Chemotherapy and Targeted therapy. On the basis of Drug type the market is segmented into Corticosteroids and Immunomodulatory agents. Due to much lesser side effects faced during targeted therapy, it is growing at a much higher rate even though chemotheraphy market is currently dominating.

The Asia Pacific market has been geographically segmented into China, India, japan, South Korea, and Australia. China currently has the highest market share in the region, followed by India owing to the general state of the healthcare industry in the countries and the populations within them. Australia and Japan are predicted to grow at the fastest rates due to the increasing number of myeloma cases within them.

Enquire about the report: http://www.marketdataforecast.com/market-reports/asia-pacific-melanoma-therapeutics-market-854/inquire

The major companies that have a wide product portfolio of treatment options available are Abbvie, Ablynx NV, Mirna Therapeutics, Redhill Biopharma, MimiVax LLC, Teva Pharmaceuticals, and Johnson and Johnson, to name a few. They have many products in their pipeline and are constantly seeking new technologies that would make treatment of cancers easier

For more reports related to cancer:
Asia Pacific Tumor Ablation market: http://www.marketdataforecast.com/market-reports/asia-pacific-tumor-ablation-market-476/

About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia Pacific Multiple Myeloma therapeutics market growing at a CAGR of 5.5% here

News-ID: 591569 • Views: 142

More Releases from Market Data Forecast

Veterinary Vaccines market value is estimated to grow at a CAGR of 5.5% to incre …
Overview: Veterinary Vaccines Market has seen significant growth over the past few years, due to alarm of imminent epidemics that have led to substantial losses, particularly in poultry segment. View sample and decide: https://www.marketdataforecast.com/market-reports/veterinary-vaccines-market-75/customize-report Market views: Global Veterinary Vaccines market value is estimated to grow at a CAGR of 5.5% to increase to reach a market value to USD 8.46 Billion by 2023. Drivers and restraints: Veterinary Vaccine market has displayed a noteworthy growth in recent years which
Protein Labelling Market Global Growth, Trends, And Forecast To 2024
Recent developments: Proteins are the biggest and most essential biomolecules in a living life form, as they are imperative to the working of a creature. When they are shaped inside a cell, proteins associate with different biomolecules and do jobs to keep the cell alive. Merck's FITC labeling kit gives intends to rapidly and just mark antibodies or different proteins with fluorescein. Coordinate marking of the essential immune response disposes of the
Agricultural biotechnology market– Dupont opened its integrated science and bi …
Recent Developments Du Pont is a science and technology company. This company introduce agriculture products, containing the soybean seed and hybrid corn varients mainly under the brand named Pioneer, canola, sorghum, sunflower,  wheat, and rice seeds; silage inoculants, and insect,  weed, disease control products, DuPont introduced its first integrated science and biotechnology center, the DuPont Knowledge Center (DKC) in Hyderabad, Telangana state, in 2008. It is a 20-acre campus with a recent
The endovenous ablation segment is expected to command the major share of the Eu …
Overview The Europe Varicose Vein Treatment Market was worth USD 95.4 million in 2018 and estimated to be growing at a CAGR of 6.3%, to reach USD 129.49 million by 2023. The varicose vein treatment market is mainly driven by the rising cases of varicose veins. This condition of enlarged veins appears mostly in feet and legs. It can be caused by pregnancy, hormonal changes, genetic disorders and high blood pressure. View a

All 5 Releases


More Releases for Asia

RAMPF Korea – Producing in Asia for Asia
Joint Venture for the Asian markets – The international RAMPF Group has realigned the cooperation with its long-standing partner Orient Dosiertechnik from Korea with the founding of RAMPF Korea Co., Ltd. The new company based in Hwaseong City is developing and producing mixing and dispensing systems specifically for the Asian markets. Within the framework of the new joint venture based in Hwaseong City, mixing and dispensing systems are being developed and
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022. 23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property
MES: Expansion in Asia
Berlin, November 24, 2014: Model Engineering Solutions (MES), the Berlin-based specialist for model-based software development, has significantly expanded its business in Asia. In recent years, MES has built up a network of local partners in Japan, Korea, China, and India in order to benefit from the growing market and increasing interest in model-based development and ISO 26262 in Asia. Asia: Driving force in the automotive industry The automotive industry continues
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia Equipping Asia’s navies with the latest diving technology for asymmetric warfare and operations SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting
UDT Asia 2011
Clarion Events hosts the Undersea Defence Technology (UDT) Asia 2011 conference and exhibition to bring senior naval and industry personnel together to cover underwater developments in the region Singapore, May 30 – Clarion Events is hosting UDT Asia on 30 November – 1 December 2011. The event brings together the undersea defence community in Asia, featuring top regional naval speakers, who will be addressing the latest underwater requirements for Asian navies. According
eltherm goes Asia
Finally all preparations are finished and the new subsidiary of eltherm GmbH, eltherm Asia Pacific Pte Ltd has commenced operations in Singapore on 1st April 2010. To celebrate the starting shot, an opening celebration was held in the afternoon of 28th July in the office premises followed by a get together dinner and drinks in the evening at a pub. A total of 62 guests attended the event with the